Focus: CSL Behring is a specialty biologics company headquartered in Bradley, IL, focused on rare diseases, neurology, infectious diseases, nephrology, and cardiovascular conditions through a pipeline of immunoglobulins, coagulation factors, and novel biologics. The company operates at scale with 119 active job openings and a robust clinical development portfolio.
Profile data last refreshed 8h ago · AI intelligence enriched 2w ago
Contracting — net -21 jobs in 30d
141 added, 162 removed. Active reduction in progress.
CSL Behring is an actively growing specialty biotech with meaningful pipeline depth and strong hiring momentum, but lack of financial transparency creates uncertainty about sustainability and strategic focus.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for CSL Behring
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from CSL Behring's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo